President Trump is reviewing policy proposals aimed at expanding access to in vitro fertilization (IVF), following his February 18, 2025, executive order recognizing infertility as a medical condition and calling for reduced out-of-pocket costs for fertility treatments.
While the initial proposal submission deadline has passed, federal officials have yet to announce next steps, leaving health insurers and providers awaiting clarity.
The executive order signals a potential shift in federal priorities, treating infertility not as an elective choice but as a health issue. This could influence insurance coverage, regulatory support, provider training, and public outreach. Currently, access to IVF and fertility treatments varies widely depending on state mandates, health plan policies, and local regulations.
State-Level Initiatives Lead the Way
In the absence of federal mandates, several states are expanding IVF access. Tennessee’s Fertility Treatment and Contraceptive Act took effect July 1, 2025, while Virginia’s House Bill 1609 directs the state’s Health Insurance Reform Commission to consider including infertility coverage.
Georgia’s House Bill 428, effective the same day, explicitly protects IVF access, and California’s Senate Bill 729 requires large-group, fully insured plans to cover infertility treatments, though implementation is postponed to January 1, 2026, with state employee coverage beginning in July 2027.
Impact on Federal Employees and Insurers
Federal employees could see near-term changes through the Federal Employees Health Benefits (FEHB) program, the largest employer-sponsored insurance pool in the U.S. Coverage decisions here may influence both public and private insurers nationwide. Momentum for FEHB reforms predates the executive order, with the Family Building FEHB Fairness Act, introduced in 2023 and 2025, seeking mandatory inclusion of assisted reproductive treatments in federal plans.
For private insurers, expanded FEHB coverage could trigger pressure to reevaluate IVF benefits, creating ripple effects across the healthcare sector.
Opportunities and Challenges for Providers
The executive order may enable clinics and fertility providers to reach more patients, particularly in underserved communities, while encouraging investment in staff, technology, and facilities. Reduced patient costs could increase demand, fostering growth and revenue opportunities.
At the same time, expanded access may bring heightened regulatory scrutiny, requiring clinics to maintain high-quality standards, patient safety protocols, and transparent pricing. Providers who adopt multidisciplinary approaches—including OB/GYNs, urologists, mental health professionals, and genetic counselors—are likely to be best positioned to deliver comprehensive, patient-centered care.
While the federal policy landscape remains in flux, state-level legislation continues to drive change. Clinics and providers that adapt proactively may benefit from increased patient access, innovation in reproductive healthcare, and long-term growth opportunities in fertility treatment services.
